An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (interleukin–2) and Ipilimumab (yervoy) in Patients with Metastatic Melanoma
OncoImmunology(2021)
Key words
metastatic melanoma,ipilimumab,high dose interleukin-2,clinical trial
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined